Skip to content
ppharmaranks
Menu

Best treatments for liposarcoma

4 products may treat liposarcoma, spanning FDA drug classes such as microtubule inhibitor, alkylating drug. The current highest-rated option is halaven. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for liposarcoma, none are yet flagged as generics in our price data, spanning classes such as microtubule inhibitor, alkylating drug. 2 of 4 carry a safety score, from 66 to 70 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for liposarcoma — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated October 10, 2026·How we rate

Top-rated picks for liposarcoma: 1. Halaven · 2. Evdi · 3. Eribulin Mesylate

Top-rated treatments for liposarcoma, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100—View →
266/100—View →
3Not yet rated—View →
4Not yet rated—View →

Full ranking · 4 treatments

Frequently asked

What treats liposarcoma?
Our catalog lists 4 products that may treat liposarcoma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is halaven.
What is the best-rated treatment for liposarcoma?
By our independent recall-safety rating — not an efficacy measure — halaven ranks highest among the products we list for liposarcoma. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat liposarcoma?
Treatments for liposarcoma span FDA drug classes including microtubule inhibitor, alkylating drug. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.

Where this ranking comes from

Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.